Kroeger Christopher A. 4

4 · MapLight Therapeutics, Inc. · Filed Oct 28, 2025

Form 4

Period: 2025-10-27

DirectorChief Executive Officer

Transactions

Award
Voting Common Stock
2025-10-27+225,693→ 225,693 total
Award
Employee Stock Option (right to buy)
2025-10-27+916,164→ 916,164 total
Exercise: $17.00Exp: 2035-10-26→ Voting Common Stock (916,164 underlying)
Conversion
Series C Preferred Stock
2025-10-28−65,477→ 0 total
→ Voting Common Stock (3,895 underlying)
Conversion
Voting Common Stock
2025-10-28+3,895→ 229,588 total

Holdings

Footnotes (5)

[F1]Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
[F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
[F3]The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's IPO for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
[F4]The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
[F5]1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file